Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Waldmann

Showing results (61-70 of 442) with videos related to

Pageof 45
Sort By:
Blood|May 16, 1998
Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH UsersG Hale, H Waldmann
Current Opinion in Immunology|October 6, 1999
Optimism after much pessimism: what next?C Milstein, H Waldmann
Immunology|March 1, 1975
The inter-relationship of antigenic structure, thymus-independence and adjuvanticity. IV. A general model for B-cell inductionH Waldmann, A Munro
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 4, 2001
Enantiospecific synthesis of the (9S,18R)-diastereomer of the leukocyte adhesion inhibitor cyclamenol AM Nazaré, H Waldmann
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 7, 2001
Synthesis of lipidated eNOS peptides by combining enzymatic, noble metal- and acid-mediated protecting group techniques with solid phase peptide synthesis and fragment condensation in solutionR Machauer, H Waldmann
Immunology|November 1, 1977
The influence of antigen presentation on the generation of T-helper cells with different functionsH Waldmann, H Pope
Bone Marrow Transplantation|February 1, 1995
Availability of Campath-1 antibodies for bone marrow transplantationG Hale, H Waldmann
Current Opinion in Immunology|October 31, 1998
Infectious toleranceS Cobbold, H Waldmann
Immunology Today|October 8, 2014
Limiting dilution analysis of cells of the immune system II: What can be learnt?H Waldmann, I Lefkovits
Der Internist|July 27, 1999
[Principles of ambulatory drug withdrawal treatment]H Waldmann, H E Hasse
Pageof 45

Showing results (61-70 of 442) with videos related to

Sort By:
Pageof 45
Blood|May 16, 1998
Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH UsersG Hale, H Waldmann
Current Opinion in Immunology|October 6, 1999
Optimism after much pessimism: what next?C Milstein, H Waldmann
Immunology|March 1, 1975
The inter-relationship of antigenic structure, thymus-independence and adjuvanticity. IV. A general model for B-cell inductionH Waldmann, A Munro
Chemistry (Weinheim an Der Bergstrasse, Germany)|September 4, 2001
Enantiospecific synthesis of the (9S,18R)-diastereomer of the leukocyte adhesion inhibitor cyclamenol AM Nazaré, H Waldmann
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 7, 2001
Synthesis of lipidated eNOS peptides by combining enzymatic, noble metal- and acid-mediated protecting group techniques with solid phase peptide synthesis and fragment condensation in solutionR Machauer, H Waldmann
Immunology|November 1, 1977
The influence of antigen presentation on the generation of T-helper cells with different functionsH Waldmann, H Pope
Bone Marrow Transplantation|February 1, 1995
Availability of Campath-1 antibodies for bone marrow transplantationG Hale, H Waldmann
Current Opinion in Immunology|October 31, 1998
Infectious toleranceS Cobbold, H Waldmann
Immunology Today|October 8, 2014
Limiting dilution analysis of cells of the immune system II: What can be learnt?H Waldmann, I Lefkovits
Der Internist|July 27, 1999
[Principles of ambulatory drug withdrawal treatment]H Waldmann, H E Hasse
Pageof 45